Floatz logo

ETOPOSIDE

Hepatocellular Carcinoma

PfizerSmall moleculePhase 3Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
65/ 100

Competitive context

262 Active assets in the Hepatocellular Carcinoma cohort.

Asset / SponsorPhaseRating
Theprubicin
RWTH Aachen University
Phase 4BB
Ethiodized Oil
RWTH Aachen University
Phase 4BB
FLUOROURACILUM
Li Qiang
Phase 4BB
Eloxatin
Li Qiang
Phase 4BB
Inno-206
VA Office of Research and Development
Phase 4BB

View all 50 →

Same molecule, other indications

ETOPOSIDE is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →